EUVIMEDDescoperă EUVIMED
Open access · CC BY 4.0

Generalizing Conditional Average Treatment Effects From Nested Randomized Trials to Trial‐Eligible Individuals

Lan Wen iD, Issa J Dahabreh iD, Yu-Han Chiu iD

Statistics in Medicine · 2026

DOI: 10.1002/sim.70767 ↗

At a glance

Journal article in Statistics in Medicine, 2026. Written by Lan Wen and 2 co-authors. Institution: Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada. Major MEDLINE topics: Randomized Controlled Trials as Topic. 58 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIGMS NIH HHS, NHLBI NIH HHS, Natural Sciences and Engineering Research Council of Canada.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Randomized controlled trials often enroll participants whose characteristics differ from those of a target population. When the distribution of effect modifiers differs between trial participants and the target population, treatment effects estimated within the trial may not be directly applicable to all trial‐eligible individuals. Although substantial progress has been made in generalizing average treatment effects from randomized trials to target populations, clinical and policy decisions are often informed by conditional average treatment effects (CATEs) that characterize heterogeneity across selected effect modifiers in the target population. In this work, we provide a unified approach for estimating CATEs in a target population of trial‐eligible individuals under a nested trial design. Our approach first estimates nuisance functions using data‐adaptive methods and constructs pseudo‐outcomes from conditional influence functions. These pseudo‐outcomes are subsequently regressed on pre‐specified effect modifiers using local linear (kernel) regression to obtain a smoothed estimate of the CATE function. We establish asymptotic properties under sample splitting and cross‐fitting, and provide conditions under which first‐stage nuisance estimation has negligible impact on the final estimator. We assess the finite‐sample performance of the proposed estimator via simulation studies, and illustrate its practical use through an application to the Coronary Artery Surgery Study (CASS).

Subjects

MeSH terms (MEDLINE)

Randomized Controlled Trials as TopicHumansTreatment Effect HeterogeneityComputer SimulationModels, StatisticalTreatment OutcomeResearch Design

Author keywords

conditional average treatment effectconditional influence functionsdata integrationgeneralizabilitynested trial designrandomized controlled trials

Authors and institutions

  • Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Ontario, Canada.
  • Department of Epidemiology and Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.
  • Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, Rhode Island, USA.

ORCID profiles: Lan Wen, Issa J Dahabreh, Yu-Han Chiu

Funding

  • NIGMS NIH HHS
  • NHLBI NIH HHS
  • Natural Sciences and Engineering Research Council of Canada
  • NLM NIH HHS
  • Patient-Centered Outcomes Research Institute
  • National Institute of General Medical Sciences
  • U.S. National Library of Medicine
  • National Heart, Lung, and Blood Institute

Cite

APA

Wen, L., Dahabreh, I. J., & Chiu, Y. H. (2026). Generalizing Conditional Average Treatment Effects From Nested Randomized Trials to Trial‐Eligible Individuals. Statistics in Medicine. https://doi.org/10.1002/sim.70767

Vancouver

Wen L, Dahabreh IJ, Chiu YH. Generalizing Conditional Average Treatment Effects From Nested Randomized Trials to Trial‐Eligible Individuals. Statistics in Medicine. 2026. doi:10.1002/sim.70767

BibTeX
@article{Wen2026,
  author = {Wen, Lan and Dahabreh, Issa J and Chiu, Yu-Han},
  title = {Generalizing Conditional Average Treatment Effects From Nested Randomized Trials to Trial‐Eligible Individuals},
  journal = {Statistics in Medicine},
  year = {2026},
  doi = {10.1002/sim.70767}
}
Start for free →